American Regent/Luitpold has discontinued manufacturing Lidocaine HCl Injection, USP Discontinuation of the manufacture of the drug 2%, 50 mL vial package of 25 (NDC 00517-0626-25) Lidocaine HCl (Xylocaine®) 2% (20mg/ml), 5ml LifeShield® Glass Abboject® Syringe (for Cardiac Use Only) - 10/Box The elimination half-life of lidocaine following an intravenous bolus injection is typically 1.5 to 2 hours. There are data that indicate There are data that indicate that the half-life may be 3 hours or longer following infusions of greater than 24 hours. CLICK HERE CLICK HERE CLICK HERE CLICK HERE CLICK HERE. This amazing site, which includes experienced business for 9 years, is one of the leading pharmacies on the Internet. 2% Lidocaine Hydrochloride Injection USP Page 6 of 9 0.4% Lidocaine Hydrochloride and 5% Dextrose Injection USP doses in some patients. Cross-sensitivity between lidocaine and procainamide or lidocaine and quinidine has not been Lidocaine Hydrochloride Injection, USP (2%) (20 mg/mL) 0409-4903-34 100 mg/5 mL LifeShield™ Abboject™ Syringe 5 x 1, I.V. For Cardiac Arrhythmias Lot Number 79-317-DK: Event Date : Event Type Malfunction Event Description There was a delay in the medication -lidocaine- administration due to failure of the abboject to release medication. For example, in a child of 5 years weighing 50 lbs the dose of Lidocaine HCl should not exceed 75 to 100 mg (1.5 to 2 mg/lb). The use of even more dilute solutions (ie, 0.25 to 0.5%) and total dosages not to exceed 3 mg/kg (1.4 mg/lb) are recommended for induction of intravenous regional anesthesia in children. Hospira’s lidocaine for injection (1% or 2%) is available in 5mL pre-filled syringes. Available in Ansyr™ or Lifeshield™ Abboject™ pre-filled syringes. Lidocaine Hydrochloride, USP is chemically designated 2-(diethylamino)-N-(2,6-dimethylphenyl)-acetamide monohydrochloride monohydrate, a white powder freely soluble in water. The molecular weight is 288.82. It has the following structural formula.